regulatory
confidence high
sentiment negative
materiality 0.85
Cycurion, Inc. (CYCU): Nasdaq/NYSE listing notice — Cycurion receives Nasdaq delisting notice; plans 30:1 reverse split and appeal
Cycurion, Inc.
- Nasdaq staff determined to delist CYCU common stock due to bid price below $1 for 30 consecutive days; appeal filed Oct 20 stays suspension pending hearing (30-45 days).
- Board approved 30:1 reverse stock split effective Oct 27 to attempt to regain compliance with Bid Price Rule.
- Announced five new contracts totaling ~$1M in value, adding $75K monthly recurring revenue from healthcare and pharma sectors.
- Engaged counsel to investigate and pursue legal action against individuals allegedly spreading false information and engaging in naked short selling.